AFL Stock Overview
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Aflac Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$77.80 |
| 52 Week High | US$79.20 |
| 52 Week Low | US$59.00 |
| Beta | 0.91 |
| 1 Month Change | 3.87% |
| 3 Month Change | 5.85% |
| 1 Year Change | 29.45% |
| 3 Year Change | 77.10% |
| 5 Year Change | 80.20% |
| Change since IPO | 355.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFL | DE Insurance | DE Market | |
|---|---|---|---|
| 7D | -1.8% | -5.6% | -0.4% |
| 1Y | 29.5% | 25.8% | 3.4% |
Return vs Industry: AFL exceeded the German Insurance industry which returned 28.3% over the past year.
Return vs Market: AFL exceeded the German Market which returned 4.9% over the past year.
Price Volatility
| AFL volatility | |
|---|---|
| AFL Average Weekly Movement | 2.9% |
| Insurance Industry Average Movement | 2.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: AFL has not had significant price volatility in the past 3 months.
Volatility Over Time: AFL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 12,785 | Dan Amos | https://www.aflac.com |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Aflac Incorporated Fundamentals Summary
| AFL fundamental statistics | |
|---|---|
| Market cap | €45.12b |
| Earnings (TTM) | €4.29b |
| Revenue (TTM) | €17.23b |
10.3x
P/E Ratio2.6x
P/S RatioIs AFL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFL income statement (TTM) | |
|---|---|
| Revenue | US$18.70b |
| Cost of Revenue | US$10.08b |
| Gross Profit | US$8.62b |
| Other Expenses | US$3.96b |
| Earnings | US$4.66b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 8.10 |
| Gross Margin | 46.10% |
| Net Profit Margin | 24.91% |
| Debt/Equity Ratio | 41.7% |
How did AFL perform over the long term?
See historical performance and comparison